Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 7/20 | 0.52 |
| ▸ | CES2 | O00748 | 6/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1254294 | 0.87 | ATM (0.48) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL8582690 | 0.85 | ATM (0.46) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL814927 | 0.85 | CES2 (0.52) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL628981 | 0.83 | ATM (0.45) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL815083 | 0.81 | PTGS2 (0.57) | ATMCES1CES2ESR1PTGS2 | |
| SCHEMBL1774826 | 0.81 | ATM (0.43) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL6316616 | 0.80 | ATM (0.41) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL6062883 | 0.79 | ALDH1A1 (0.50) | ATMCES1CES2SMN1; SMN2L3MBTL1 | |
| SCHEMBL2358948 | 0.79 | ATM (0.42) | ATMCES1CES2ESR1CYP19A1 | |
| SCHEMBL2353597 | 0.79 | CYP19A1 (0.44) | ATMCES1CES2ESR1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4141038-B1 | WOOD MATERIAL AND BINDER COMPOSITION AND METHOD FOR PRODUCING A WOOD MATERIAL | SWISS KRONO Tec AG (CH) | 2024-01-10 | — | — | EP | claimed |
| CN-109369835-A | For the cyclopentadienyl rare-earth metal carbon monoxide-olefin polymeric of alpha-olefine polymerizing and its application | 朱博源 | 2019-02-22 | — | — | CN | claimed |
| CN-109369837-A | A kind of metallocene catalyst compositions and its application for alpha-olefine polymerizing | 朱博源 | 2019-02-22 | — | — | CN | claimed |
| CN-108384469-A | A kind of environment-friendly type wood seam filling agent | 张彩萍 | 2018-08-10 | — | — | CN | claimed |
| EP-2797996-A1 | REFLECTOR FOR LIGHT-EMITTING DEVICES | Ticona LLC (US) | 2014-11-05 | — | — | EP | claimed |
| WO-2013101277-A1 | REFLECTOR FOR LIGHT-EMITTING DEVICES | TICONA LLC (US) | 2013-07-04 | — | — | WO | claimed |
| US-7923465-B2 | CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant | GLENMARK PHARMACEUTICALS S.A. (CH) | 2011-04-12 | — | — | US | claimed |
| EP-1902034-B1 | NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS SA (CH) | 2011-03-30 | — | — | EP | claimed |
| WO-2011031325-A2 | ANION EXCHANGE POLYMER ELECTROLYTES | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2011-03-17 | — | — | WO | claimed |
| WO-2010080544-A1 | CLEANING COMPOSITIONS AND METHODS | HONEYWELL INTERNATIONAL, INC. (US) | 2010-07-15 | — | — | WO | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| US-6495725-B2 | USEFUL AS CHEMICAL INTERMEDIATES FOR PROSTAGLANDINS AND DRUGS | CHISSO CORPORATION (JP) | 2002-12-17 | — | — | US | claimed |
| US-20020028958-A1 | Process for the preparation of optically active enones and intermediates thereof | JNC CORPORATION (JP) | 2002-03-07 | — | — | US | claimed |
| EP-0901460-A1 | A PROCESS FOR THE PREPARATION OF 5-AMINO-2,4,6-TRIIODO-1,3-BENZENEDICARBOXYLIC ACID DERIVATIVES | BRACCO IMAGING S.p.A. (IT) | 1999-03-17 | — | — | EP | claimed |
| WO-1998024757-A1 | A PROCESS FOR THE PREPARATION OF 5-AMINO-2,4,6-TRIIODO-1,3-BENZENEDICARBOXYLIC ACID DERIVATIVES | DIBRA S.P.A. (IT) | 1998-06-11 | — | — | WO | claimed |
| US-4801706-A | ANTIARRHYTHMIA HYPOTENSIVE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-01-31 | — | — | US | claimed |
| EP-0073566-A1 | Methods and compositions for combating soil pests | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-03-09 | — | — | EP | claimed |
| US-4172197-A | BACTERICIDES | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1979-10-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | ATM 3933/4885CES1 4486/4885CES2 4281/4885 |
| US-20020028958-A1 | Process for the preparation of optically active enones and intermediates thereof | HSD17B7, NR3C2, CYP11B1 | ATM 3816/4885CES1 1281/4885CES2 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.